Evidence map›Paper›PMID 37246786›Full record

ArticleEpigenetics2023

The UHRF1 protein is a key regulator of retrotransposable elements and innate immune response to viral RNA in human cells.

R E Irwin, C Scullion, S J Thursby, M Sun, A Thakur, L Hilman, B Callaghan, P D Thompson, D J McKenna, S B Rothbart and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Epigenetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
6.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

R E IrwinBiomedical Sciences, Ulster University, Coleraine, UK.ORCID 0000-0002-6137-1716
C ScullionBiomedical Sciences, Ulster University, Coleraine, UK.
S J ThursbyBiomedical Sciences, Ulster University, Coleraine, UK.
M SunCellular and Molecular Medicine Program, Division of Oncology, Johns Hopkins School of Medicine, St., Baltimore, MD, USA.
A ThakurBiomedical Sciences, Ulster University, Coleraine, UK.
L HilmanBiomedical Sciences, Ulster University, Coleraine, UK.
B CallaghanBiomedical Sciences, Ulster University, Coleraine, UK.
P D ThompsonDepartment of Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA.
D J McKennaBiomedical Sciences, Ulster University, Coleraine, UK.
S B RothbartNutrition Innovation Centre for Food and Health, Biomedical Sciences, Ulster University, Coleraine, UK.
Guoliang XuCellular and Molecular Medicine Program, Division of Oncology, Johns Hopkins School of Medicine, St., Baltimore, MD, USA.
C P WalshBiomedical Sciences, Ulster University, Coleraine, UK.ORCID 0000-0001-9921-7506
University of Ulster · GBShanghai Institutes for Biological Sciences · CNVan Andel Institute · USJohns Hopkins University · USPrecision Nanosystems (Canada) · CA

Funding

Molecular mechanisms of chromatin and epigenetic regulationR35GM124736 · NIGMS · VAN ANDEL RESEARCH INSTITUTE · PI ROTHBART, SCOTT · 2017 to 2021
$2.4M
Mechanisms Regulating DNA Methylation Maintenance in ChromatinR00CA181343 · NCI · VAN ANDEL RESEARCH INSTITUTE · PI ROTHBART, SCOTT · 2015 to 2017
$746k
Mechanisms Regulating DNA Methylation Maintenance in ChromatinK99CA181343 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROTHBART, SCOTT · 2014 to 2015
$211k
Medical Research Council MR/J007773/1NCI NIH HHS K99 CA181343NCI NIH HHS R00 CA181343NIGMS NIH HHS R35 GM124736
6 · The paper itself

Abstract

While epigenetic mechanisms such as DNA methylation and histone modification are known to be important for gene suppression, relatively little is still understood about the interplay between these systems. The UHRF1 protein can interact with both DNA methylation and repressive chromatin marks, but its primary function in humans has been unclear. To determine what that was, we first established stable UHRF1 knockdowns (KD) in normal, immortalized human fibroblasts using targeting shRNA, since CRISPR knockouts (KO) were lethal. Although these showed a loss of DNA methylation across the whole genome, transcriptional changes were dominated by the activation of genes involved in innate immune signalling, consistent with the presence of viral RNA from retrotransposable elements (REs). We confirmed using mechanistic approaches that 1) REs were demethylated and transcriptionally activated; 2) this was accompanied by activation of interferons and interferon-stimulated genes and 3) the pathway was conserved across other adult cell types. Restoring UHRF1 in either transient or stable KD systems could abrogate RE reactivation and the interferon response. Notably, UHRF1 itself could also re-impose RE suppression independent of DNA methylation, but not if the protein contained point mutations affecting histone 3 with trimethylated lysine 9 (H3K9me3) binding. Our results therefore show for the first time that UHRF1 can act as a key regulator of retrotransposon silencing independent of DNA methylation.

Indexed as

DNA MethylationRNA, ViralCCAAT-Enhancer-Binding ProteinsHumansImmunity, InnateInterferonsUbiquitin-Protein LigasesCCAAT-Enhancer-Binding ProteinsInterferonsRNA, ViralUbiquitin-Protein LigasesUHRF1 protein, humanDNA methylationEpigeneticsRetrotransposonsUHRF1Virus

Identifiers

PMID37246786
PMCPMC10228402
OpenAlexW4378640017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.